Brain Implant in Korea Responds to Commands Sent from Chicago 6,584 Miles Away
A wireless brain implant in Daejeon, South Korea, received and executed commands transmitted from a computer in Chicago, Illinois, 10,596 km (6,584 miles) apart, completing the operation in roughly 109 milliseconds.
Key Takeaways
- Commands sent from the U.S. reached a Korean implant in 109 ms.
- RAPIDO delivers drugs and emits light via a refillable cartridge.
- Repeated cocaine doses produced measurable movement changes over 2–4 weeks.
- Light activation prevented rats from developing a cocaine‑associated place preference.
- The system was developed by researchers at KAIST and Yonsei University.
| Metric | Value | Why it matters |
|---|---|---|
| Device name | RAPIDO | Identifies the specific implant |
| Distance between command source and implant | 10,596 km / 6,584 miles | Shows intercontinental reach |
| Response latency | ≈109 ms | Demonstrates real‑time control |
| Developed by | KAIST & Yonsei University | Highlights academic collaboration |
What is RAPIDO?
RAPIDO is a miniature, wireless implant that fits on a freely moving rat. It can deliver a substance through a tiny channel and emit light from a miniature LED.
RAPIDO’s refillable cartridge allows programmed drug doses and light stimulation to be sent over the internet.
The Intercontinental Remote Control Test
Researchers in Chicago sent a command through the internet to a computer in the Korean lab, which then relayed the instruction wirelessly to the implant. The implant responded in an average of about 109 milliseconds.
The signal traveled 10,596 km (6,584 miles) before reaching the device.
Drug Delivery Experiments
The implant delivered varying doses of cocaine directly into the nucleus accumbens, a brain region linked to reward. The doses produced corresponding changes in the rats’ movement.
These effects were reproduced two, three, and four weeks after implantation, demonstrating repeatable, controlled delivery over several weeks.
Repeated doses produced measurable behavioral changes, confirming long‑term reliability.
Optogenetics Experiments
In a separate study, rats received cocaine injections into their abdomens, isolating the effect of light. Light from the implant activated the RhoA signaling pathway during conditioning.
Rats exposed to light did not develop a preference for the cocaine‑associated compartment, unlike those that received cocaine without light.
Light activation via RAPIDO blocked the development of drug‑associated place preference.
Implications and Future Directions
Remote control could reduce experimenter interference, allowing scientists in different locations to participate in the same study. However, long‑term safety and reliability in the human brain remain untested.
A clinical device would need further testing of biocompatibility, drug delivery, and fail‑safe controls. Optogenetics also requires safe delivery of light‑sensitive genes.
The researchers view RAPIDO as a research platform that could help develop and evaluate future therapeutic strategies, rather than a clinical device itself.
The study was published in Science Advances.
Why it Matters
RAPIDO demonstrates that a brain implant can be controlled from another continent in real time, opening possibilities for remote neuroscience experiments and potentially reducing the need for repeated surgeries in animal studies.
Its ability to deliver drugs and light on demand could accelerate research into neural mechanisms of behavior and the development of novel treatments for neuropsychiatric disorders.
Frequently Asked Questions
What is RAPIDO?
A wireless, refillable brain implant that can deliver drugs and emit light, designed for use in freely moving rats.
How far can commands travel?
Commands were successfully sent from Chicago to a Korean implant 10,596 km (6,584 miles) away.
What is the response time?
The implant responded in about 109 milliseconds on average.
Can RAPIDO be used in humans?
The device is currently a research platform; clinical use would require extensive safety and biocompatibility testing.
What were the main experimental findings?
Repeated cocaine delivery produced measurable behavioral changes over weeks, and light activation prevented rats from developing a cocaine‑associated place preference.
Bottom Line
RAPIDO proves that a brain implant can be operated remotely across continents, reliably deliver drugs and light, and influence behavior in animal models. While still a research tool, it lays groundwork for future studies that could transform neuroscience and therapeutic development.
Reporting based on: original source.
Comments
Post a Comment